SBC Medical Group Holdings Incorporated (SBC) Financial Ratios
3 years of historical data (2022–2024) · Industrials · Consulting Services
EV/EBITDA
↑
2.92
↓-59% vs avg
5yr avg: 7.17
30Y Low4.5·High11.3
P/FCF
↑
19.17
↓-33% vs avg
5yr avg: 28.49
30Y Low25.7·High31.3
P/B Ratio
↑
1.59
↓-58% vs avg
5yr avg: 3.74
30Y Low1.4·High7.1
ROE
↑
27.5%
↓+28% vs avg
5yr avg: 21.6%
30Y Low6%·High31%
Debt/EBITDA
↓
0.16
↓-53% vs avg
5yr avg: 0.35
30Y Low0.2·High0.6
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
SBC Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
SBC Medical Group Holdings Incorporated trades at 6.7x earnings, 94% below its 5-year average of 105.1x, sitting at the 0th percentile of its historical range. Compared to the Industrials sector median P/E of 25.5x, the stock trades at a discount of 74%. On a free-cash-flow basis, the stock trades at 19.2x P/FCF, 33% below the 5-year average of 28.5x.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Market Cap | $329M | $537M | $1.0B | $154M |
| Enterprise Value | $216M | $424M | $934M | $118M |
| P/E Ratio → | 6.65 | 11.52 | 25.77 | 277.93 |
| P/S Ratio | 1.60 | 2.61 | 5.24 | 0.88 |
| P/B Ratio | 1.59 | 2.75 | 7.05 | 1.42 |
| P/FCF | 19.17 | 31.26 | 25.72 | — |
| P/OCF | 16.00 | 26.08 | 20.03 | — |
P/E links to full P/E history page with 30-year chart
SBC EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
SBC Medical Group Holdings Incorporated's enterprise value stands at 2.9x EBITDA, 59% below its 5-year average of 7.2x. The Industrials sector median is 13.8x, placing the stock at a 79% discount on an enterprise-value basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| EV / Revenue | — | 2.06 | 4.83 | 0.68 |
| EV / EBITDA | 2.92 | 5.72 | 11.27 | 4.53 |
| EV / EBIT | 3.08 | 5.77 | 12.69 | 4.98 |
| EV / FCF | — | 24.69 | 23.69 | — |
SBC Profitability
Margins and return-on-capital ratios measuring operating efficiency
SBC Medical Group Holdings Incorporated earns an operating margin of 34.2%, significantly above the Industrials sector average of 4.9%. Operating margins have expanded from 11.6% to 34.2% over the past 3 years, signaling improving operational efficiency. ROE of 27.5% indicates solid capital efficiency, compared to the sector median of 8.2%. ROIC of 72.3% represents excellent returns on invested capital versus a sector median of 6.3%.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Gross Margin | 76.0% | 76.0% | 70.9% | 65.9% |
| Operating Margin | 34.2% | 34.2% | 36.5% | 11.6% |
| Net Profit Margin | 22.7% | 22.7% | 20.3% | 3.6% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ROE | 27.5% | 27.5% | 31.3% | 5.9% |
| ROA | 17.8% | 17.8% | 16.3% | 2.8% |
| ROIC | 72.3% | 72.3% | 78.0% | 20.9% |
| ROCE | 37.9% | 37.9% | 48.6% | 16.2% |
SBC Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
SBC Medical Group Holdings Incorporated carries a Debt/EBITDA ratio of 0.2x, which is very conservative (95% below the sector average of 3.2x). The company holds a net cash position — cash of $125M exceeds total debt of $12M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns. Interest coverage of 2484.2x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Debt / Equity | 0.06 | 0.06 | 0.16 | 0.15 |
| Debt / EBITDA | 0.16 | 0.16 | 0.28 | 0.62 |
| Net Debt / Equity | — | -0.58 | -0.56 | -0.33 |
| Net Debt / EBITDA | -1.52 | -1.52 | -0.97 | -1.37 |
| Debt / FCF | — | -6.57 | -2.03 | — |
| Interest Coverage | 2484.23 | 2484.23 | 1560.10 | 639.85 |
Net cash position: cash ($125M) exceeds total debt ($12M)
SBC Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
SBC Medical Group Holdings Incorporated's current ratio of 3.01x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 1.12x to 3.01x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Current Ratio | 3.01 | 3.01 | 1.79 | 1.12 |
| Quick Ratio | 2.99 | 2.99 | 1.76 | 1.10 |
| Cash Ratio | 2.04 | 2.04 | 1.11 | 0.53 |
| Asset Turnover | — | 0.77 | 0.75 | 0.77 |
| Inventory Turnover | 33.02 | 33.02 | 18.19 | 43.94 |
| Days Sales Outstanding | — | 85.63 | 100.20 | 91.47 |
SBC Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
SBC Medical Group Holdings Incorporated does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 15.0% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Dividend Yield | — | — | — | — |
| Payout Ratio | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Earnings Yield | 15.0% | 8.7% | 3.9% | 0.4% |
| FCF Yield | 5.2% | 3.2% | 3.9% | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $97M | $94M | $15M |
Peer Comparison
Compare SBC with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 SBCYou | $329M | 6.7 | 2.9 | 19.2 | 76.0% | 34.2% | 27.5% | 72.3% | 0.2 |
 SKIN | $118M | -5.7 | 7331.2 | 3.2 | 65.3% | -6.9% | -16.8% | -6.8% | 10519.4 |
 INMD | $882M | 9.7 | 6.9 | 10.5 | 78.5% | 23.0% | 13.5% | 13.5% | 0.2 |
 SSKN | $7M | -0.7 | — | — | 56.9% | -27.6% | -114.2% | -38.9% | — |
 NVCR | $2B | -13.8 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 LASE | $16M | -3.3 | — | — | 43.4% | -189.3% | -20.9% | -42.1% | — |
 AEYE | $100M | -32.4 | — | — | 78.3% | -7.9% | -43.2% | -42.4% | — |
 ISRG | $161B | 57.6 | 43.6 | 64.7 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 |
 EW | $48B | 45.2 | 25.4 | 35.7 | 78.1% | 27.0% | 10.5% | 15.5% | 0.4 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
 GMED | $12B | 21.7 | 18.5 | 19.5 | 67.4% | 16.3% | 12.3% | 8.9% | 0.2 |
| Industrials Median | — | 25.5 | 13.8 | 20.7 | 32.7% | 4.9% | 8.2% | 6.3% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 3 years · Updated daily
See SBC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SBC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SBC vs SKIN
Side-by-side business, growth, and profitability comparison vs The Beauty Health Company.
Start ComparisonSBC — Frequently Asked Questions
Quick answers to the most common questions about buying SBC stock.
What is SBC Medical Group Holdings Incorporated's P/E ratio?
SBC Medical Group Holdings Incorporated's current P/E ratio is 6.7x. The historical average is 18.6x.
What is SBC Medical Group Holdings Incorporated's EV/EBITDA?
SBC Medical Group Holdings Incorporated's current EV/EBITDA is 2.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 7.2x.
What is SBC Medical Group Holdings Incorporated's ROE?
SBC Medical Group Holdings Incorporated's return on equity (ROE) is 27.5%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 21.6%.
Is SBC stock overvalued?
Based on historical data, SBC Medical Group Holdings Incorporated is trading at a P/E of 6.7x. Compare with industry peers and growth rates for a complete picture.
What are SBC Medical Group Holdings Incorporated's profit margins?
SBC Medical Group Holdings Incorporated has 76.0% gross margin and 34.2% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
How much debt does SBC Medical Group Holdings Incorporated have?
SBC Medical Group Holdings Incorporated's Debt/EBITDA ratio is 0.2x, indicating low leverage. A ratio below 2x is generally considered financially healthy.